Speak to a GMP / GDP Consultant now: 020 7692 5259phone info@inglasia.comemail

EU Import & Batch Release

As a Manufacturer Importation Authorisation (MIA) Holder in the EU, we will take care of the import, release, storage and distribution of your medicines in the EU

EU Marketing Authorisation Holders (MAH) require a site in Europe to be named on their products Marketing Authorisation as the site of EU Batch release.

Let us take care of this for you under our Licence.

Our dedicated facility in Dublin, Ireland can be named on your Marketing Authorisation as the site of EU import, QC testing and Qualified Person batch release.

Our dedicated Pharmaceutical warehouse is available for import and physical storage of your medicines under quarantine, whilst Quality Control samples are tested prior to our Qualified Person review of all documentation, related to the manufacturing and testing of your product.

Your product is EU Good Manufacturing Practice certified and is released and available at our facility to be picked, packed and dispatched to your customers in the EU.

Are you an EU MAH intending to supply your product in the EU?

Let Inglasia Pharma Solutions (MIA) Licence manage this for you. How do we achieve this?

API
W
e provide QP declaration for your API supplier

CDMO
W
e perform the EU GMP QP audit of your contract manufacturer and oversight of their compliance to EU GMP

EU QC
We perform the QC testing of your imported medicine

EU storage

EU Storage
We receive, store, pick and pack your product and supply to your end customer

EU QP

EU QP
We check all product documentation and our QP releases your product for EU market

Contact us to talk about how we can support you with your supply chain activities